The Patent Finder

Compounds for Inhibiting NLRP3 and Uses Thereof

Ventus Therapeutics U.S., Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 63/171,932, filed Apr 7, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,319,319Compounds for Inhibiting NLRP3 and Uses Thereof
In force
 · High confidence
UsedRemaining
Novo Nordisk A/S and Ventus Therapeutics U.S., Inc.In forceHigh confidence
US 12,281,112Compounds for Inhibiting NLRP3 and Uses Thereof
In force
 · Low confidence
Ventus Therapeutics U.S., Inc.In forceLow confidence
US 12,351,578Compounds for Inhibiting NLRP3 and Uses Thereof
In force
 · Medium confidence
Ventus Therapeutics U.S., Inc.In forceMedium confidence
Application 17/679,898Compounds for Inhibiting NLRP3 and Uses Thereof
Abandoned
Abandoned Mar 18, 2024
Ventus Therapeutics U.S., Inc.AbandonedAbandoned Mar 18, 2024
Application 18/534,906Compounds for Inhibiting NLRP3 and Uses Thereof
Abandoned
Abandoned Aug 20, 2024
Ventus Therapeutics U.S., Inc.AbandonedAbandoned Aug 20, 2024
Application 18/763,302Compounds for Inhibiting NLRP3 and Uses Thereof
Abandoned
Abandoned Mar 4, 2025
Ventus Therapeutics U.S., Inc.AbandonedAbandoned Mar 4, 2025
Application 18/891,602Compounds for Inhibiting NLRP3 and Uses Thereof
Pending
Not granted
Ventus Therapeutics U.S., Inc.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Ventus Therapeutics U.S., Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited